Glucagon-like peptide-1 7-36: a physiological incretin in man
Mounjaro (tirzepatide) is an FDA-approved prescription injectable medication to improve blood sugar levels in adults with Type 2 diabetes
Semaglutide is a synthetic peptide widely utilised in biochemical, analytical, and in-vitro research environments , including receptor interaction studies, assay validation, and compound stability testing

Individuals with obesity are estimated to account for roughly 20 percent more GHG emissions than those within a healthy weight rangeintroducing a new dimension to the obesity conversation and the need for medical innovation in this space.[99] As average body weights increase, so too does overall energy demand.[100] Individuals with obesity require more basal energy due to increased lean mass, which supports greater body size and drives higher oxygen consumption and carbon dioxide (CO) production.[101] This results in an estimated 81 kilograms of additional CO emissions per person annually.[102] With approximately 609 million adults living with obesity globally in 2015, the total excess metabolic CO emissions produced globally could reach 609 million 81 kg = 49.1 megatonscomparable to the emissions generated by 183 million individuals of healthy weight.[103] Viewed through this lens, the case for innovation in obesity treatmentincluding the use of GLP-1 therapiesbecomes even more compelling

J Epithel Biol Pharmacol
doi: 10.1056/NEJMoa2307563 76 KuthatiYDavuluriVNGWongCS